Structured Exercise Training Program Versus Hypocaloric Hyperproteic Diet in Obese Anovulatory Infertile Patients With PCOS
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Lifestyle modifications are successfully employed in polycystic ovarian syndrome (PCOS) improving menstrual cycles and fertility. Unfortunately, the compliance over the time is very low. Recently, we have showed a high adherence to structured exercise training (SET) program in women with PCOS. The current study will be aimed to compare the efficacy of the SET program with a diet program on the reproductive function in obese anovulatory infertile PCOS patients.
| Condition | Intervention | Phase |
|---|---|---|
|
Polycystic Ovary Syndrome Anovulation Infertility |
Behavioral: Structured exercise training Behavioral: Hypocaloric hyperproteic diet |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Effects of Structured Exercise Program Versus Hypocaloric Hyperproteic Diet on the Reproductive Function in Obese Anovulatory Infertile Patients With Polycystic Ovary Syndrome: a 24-Week Prospective Study. |
- Pregnancy rate [ Time Frame: six months ]
- Menstrual frequency [ Time Frame: six months ]
- Abortion rate [ Time Frame: six months ]
- Compliance [ Time Frame: six months ]
| Enrollment: | 40 |
| Study Start Date: | January 2004 |
| Estimated Study Completion Date: | August 2006 |
Forty obese anovulatory infertile PCOS patients who wish to conceive will be allocated in two study-groups according to their desire: structured exercise training (SET) group (n. 20) will undergo a SET program, whereas diet group (n. 20) will undertake a hypocaloric hyperproteic diet. The duration of the study will be of 24 weeks. At baseline, after 12 and 24 weeks clinical, endocrine and metabolic evaluations will be performed in each patient and all reproductive events obtained throughout the study will be recorded.
Eligibility| Ages Eligible for Study: | 18 Years to 35 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- PCOS
- Anovulatory infertility
- Obesity (BMI >30)
Exclusion Criteria:
- Age <18 or >35 years
- Neoplastic, metabolic, hepatic, renal, and cardiovascular disorders or other concurrent medical illnesses
- Hypothyroidism, hyperprolactinemia, Cushing's syndrome, and non-classical congenital adrenal hyperplasia
- Current or previous (within the last six months) use of oral contraceptives, glucocorticoids, antiandrogens, ovulation induction agents, antidiabetic and anti-obesity drugs or other drugs know to affect sex hormone levels, carbohydrate metabolism, or appetite
- Organic pelvic diseases, previous pelvic surgery, suspected peritoneal factor infertility, tubal or male factor infertility or sub-fertility
Contacts and Locations| Italy | |
| "Pugliese" Hospital | |
| Catanzaro, Italy, 88100 | |
| Principal Investigator: | Stefano Palomba, MD | Department of Obstetrics and Gynecology, University "Magna Graecia" of Catanzaro |
| Principal Investigator: | Francesco Orio, MD | Department of Molecular and Clinical Endocrinology and Oncology, University "Federico II" of Naples, and Chair of Endocrinology, University "Parthenope", of Naples |
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00473538 History of Changes |
| Other Study ID Numbers: | 01/2004 |
| Study First Received: | May 14, 2007 |
| Last Updated: | November 13, 2007 |
| Health Authority: | Italy: The Italian Medicines Agency |
Keywords provided by University Magna Graecia:
|
Structured exercise training program Infertility Menstrual cycle PCOS Treatment |
Additional relevant MeSH terms:
|
Anovulation Infertility Polycystic Ovary Syndrome Ovarian Diseases Adnexal Diseases Genital Diseases, Female |
Gonadal Disorders Endocrine System Diseases Genital Diseases, Male Ovarian Cysts Cysts Neoplasms |
ClinicalTrials.gov processed this record on May 19, 2013